CHAD Therapeutics Elects New Members to Board of Directors
Sep 11, 2003
 Print this page

CHAD Therapeutics, Inc. announced that its shareholders elected the Board's nominees to the company's Board of Directors at the annual meeting held on Sept. 9, 2003, denying a seat to a dissident shareholder who waged an unsuccessful proxy contest in an attempt to elect himself to CHAD's Board.

Shareholders elected Philip Wolfstein, James M. Brophy, and Kathleen M. Fischer to two-year terms on CHAD's seven-member Board.

CHAD is in the business of developing, producing, and marketing respiratory care devices designed to improve the efficiency of oxygen delivery systems for home health care and hospital treatment of patients suffering from pulmonary diseases.

Back to Breaking News